Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Saved in:
| Title: | Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. |
|---|---|
| Authors: | Chen L; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.; Shenzhen Key Laboratory of Inflammatory and Immunologic Diseases, Shenzhen, Guangdong, China., Wang Q; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.; Shenzhen Key Laboratory of Inflammatory and Immunologic Diseases, Shenzhen, Guangdong, China., Gu M; Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.; Shenzhen Key Laboratory of Inflammatory and Immunologic Diseases, Shenzhen, Guangdong, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Jan 19; Vol. 16, pp. 1732708. Date of Electronic Publication: 2026 Jan 19 (Print Publication: 2025). |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2025.1732708 |
